Avanafil ZPHC — 50 mg × 100 tablets

Avanafil — ultra-fast PDE-5 inhibitor
100 film-coated tablets × 50 mg

• Rapid onset: peak plasma ≈15 min, faster than sildenafil or tadalafil.
• Short half-life (~6 h): less “next-day” congestion or visual haze.
• Selectivity: higher PDE-5 / PDE-6 ratio → fewer visual side-effects.
• Sample research dosing: 50–200 mg oral, 15–30 min pre-stimulus; minimal food interaction.
• Cautions: contraindicated with nitrates / α-blockers; monitor BP in cardiovascular studies.
• QC: ≥99 % API purity (HPLC); GMP tablet press; tamper-evident cap with scratch-code authenticity.